Table 1.
Proportional treatment contact in the year of onset of any anxiety disorder and median duration of delay among cases that subsequently made treatment contact
| Making treatment contact in year of onset, % (SE) | Making treatment contact by 50 years, % (SE) | Median duration of delay in years (SE) | |
|---|---|---|---|
| The Americas | |||
| Colombia | 2.9 (0.6) | 41.6 (3.9) | 26.0 (1.5) |
| Mexico | 3.6 (1.1) | 53.2 (18.2) | 30.0 (5.1) |
| USA | 11.3 (0.7) | 87.0 (2.4) | 23.0 (0.6) |
| Europe | |||
| Belgium | 19.8 (2.8) | 84.5 (4.9) | 16.0 (3.5) |
| France | 16.1 (1.8) | 93.3 (1.9) | 18.0 (1.8) |
| Germany | 13.7 (1.8) | 95.0 (2.3) | 23.0 (2.3) |
| Italy | 17.1 (2.1) | 87.3 (8.5) | 28.0 (2.2) |
| Netherlands | 28.0 (3.7) | 91.1 (2.8) | 10.0 (1.6) |
| Spain | 23.2 (2.0) | 86.6 (5.2) | 17.0 (3.2) |
| Africa and Middle East | |||
| Israel | 36.4 (0.9) | 90.7 (1.3) | 3.0 (0.1) |
| Lebanon | 3.2 (1.1) | 37.3 (11.5) | 28.0 (3.9) |
| Nigeria | 0.8 (0.5) | 15.2 (2.6) | 16.0 (4.2) |
| Asia and the Pacific | |||
| Japan | 11.2 (2.4) | 63.1 (6.2) | 20.0 (2.4) |
| PR China | 4.2 (2.0) | 44.7 (7.2) | 21.0 (3.1) |
| Oceania | |||
| New Zealand | 12.5 (0.8) | 84.2 (2.5) | 21.0 (0.8) |